riluzole has been researched along with Demyelinating Diseases in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morris, WE | 1 |
| Goldstein, J | 1 |
| Redondo, LM | 1 |
| Cangelosi, A | 1 |
| Geoghegan, P | 1 |
| Brocco, M | 1 |
| Loidl, FC | 1 |
| Fernandez-Miyakawa, ME | 1 |
1 other study available for riluzole and Demyelinating Diseases
| Article | Year |
|---|---|
Clostridium perfringens epsilon toxin induces permanent neuronal degeneration and behavioral changes.
Topics: Animals; Apoptosis; Bacterial Toxins; Behavior, Animal; Brain; Cerebral Cortex; Corpus Striatum; Dem | 2017 |